| Staci M Hestdalen, MD | |
|
1807 N Hutchinson Rd, Spokane Valley, WA 99212-2444 | |
| (509) 456-7414 | |
| (509) 624-0763 |
| Full Name | Staci M Hestdalen |
|---|---|
| Gender | Female |
| Speciality | Dermatology |
| Experience | 26 Years |
| Location | 1807 N Hutchinson Rd, Spokane Valley, Washington |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194790006 | NPI | - | NPPES |
| 8394454 | Medicaid | WA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | MD00043715 (Washington) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mountain West Derm - Blackhart Pllc | 1153609813 | 103 |
| Mountain West Derm - Blackhart Pllc | 1153609813 | 103 |
News Archive
Murad, Inc. has announced the launch of Complete Reform with Glyco Firming Complex, the latest powerhouse anti-aging treatment product in the company's award-winning Age Reform line.
Johns Hopkins researchers have uncovered strong evidence that mice have a specific set of nerve cells that signal itch but not pain, a finding that may settle a decades-long debate about these sensations, and, if confirmed in humans, help in developing treatments for chronic itch, including itch caused by life-saving medications.
Santen Inc., the U.S. subsidiary of global ophthalmic pharmaceutical company Santen Pharmaceutical Co., Ltd. today announced the European Commission (EC) has granted orphan drug status for sirolimus (DE-109) for the treatment of chronic non-infectious uveitis.
Obesity is linked to a nearly 6-fold increased risk of developing type 2 diabetes, with high genetic risk and unfavorable lifestyle also increasing risk but to a much lesser extent.
› Verified 8 days ago
| Entity Name | Mountain West Derm - Blackhart Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013557933 PECOS PAC ID: 1153609813 Enrollment ID: O20200904001722 |
News Archive
Murad, Inc. has announced the launch of Complete Reform with Glyco Firming Complex, the latest powerhouse anti-aging treatment product in the company's award-winning Age Reform line.
Johns Hopkins researchers have uncovered strong evidence that mice have a specific set of nerve cells that signal itch but not pain, a finding that may settle a decades-long debate about these sensations, and, if confirmed in humans, help in developing treatments for chronic itch, including itch caused by life-saving medications.
Santen Inc., the U.S. subsidiary of global ophthalmic pharmaceutical company Santen Pharmaceutical Co., Ltd. today announced the European Commission (EC) has granted orphan drug status for sirolimus (DE-109) for the treatment of chronic non-infectious uveitis.
Obesity is linked to a nearly 6-fold increased risk of developing type 2 diabetes, with high genetic risk and unfavorable lifestyle also increasing risk but to a much lesser extent.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Staci M Hestdalen, MD 1807 N Hutchinson Rd, Spokane Valley, WA 99212-2444 Ph: (509) 456-7414 | Staci M Hestdalen, MD 1807 N Hutchinson Rd, Spokane Valley, WA 99212-2444 Ph: (509) 456-7414 |
News Archive
Murad, Inc. has announced the launch of Complete Reform with Glyco Firming Complex, the latest powerhouse anti-aging treatment product in the company's award-winning Age Reform line.
Johns Hopkins researchers have uncovered strong evidence that mice have a specific set of nerve cells that signal itch but not pain, a finding that may settle a decades-long debate about these sensations, and, if confirmed in humans, help in developing treatments for chronic itch, including itch caused by life-saving medications.
Santen Inc., the U.S. subsidiary of global ophthalmic pharmaceutical company Santen Pharmaceutical Co., Ltd. today announced the European Commission (EC) has granted orphan drug status for sirolimus (DE-109) for the treatment of chronic non-infectious uveitis.
Obesity is linked to a nearly 6-fold increased risk of developing type 2 diabetes, with high genetic risk and unfavorable lifestyle also increasing risk but to a much lesser extent.
› Verified 8 days ago
Joel K Sears, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1807 N Hutchinson Rd, Spokane Valley, WA 99212 Phone: 509-456-7414 Fax: 509-624-0763 | |
Andrea Mead Dominey, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1807 N Hutchinson Rd, Spokane Valley, WA 99212 Phone: 509-456-7414 Fax: 509-624-0763 | |
Paul T Dunn, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1807 N Hutchinson Rd, Spokane Valley, WA 99212 Phone: 509-456-7414 Fax: 509-624-0763 | |
Dr. Robin Louise Hornung, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1807 N Hutchinson Rd, Spokane Valley, WA 99212 Phone: 509-456-7414 Fax: 509-624-0763 | |
Chadd Sukut, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1807 N Hutchinson Rd, Spokane Valley, WA 99212 Phone: 509-456-7414 Fax: 509-624-0763 | |
Joseph L Cvancara, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1807 N Hutchinson Rd, Spokane Valley, WA 99212 Phone: 509-456-7414 Fax: 509-624-0763 |